Cardiac Resynchronization Therapy (CRT Devices) Global Market Top Key Players – Abbott Laboratories (U.S.), Biotronik (Germany), LivaNova Plc. (UK) and Forecast to 2023

Global Cardiac Resynchronization Therapy (CRT Devices) Market

Description

WiseGuyReports.Com adds” Global Cardiac Resynchronization Therapy (CRT Devices) Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 “Research To Its Database.

Cardiac Resynchronization therapy is used to treat heart diseases. Devices that are used in cardiac resynchronization therapy known as CRT devices. Irregular heartbeats is known as arrhythmias that can be caused due to the various reasons such as age, damage of heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with the arrhythmias in the heart failure patients. Heart’s ventricle contractions in arrhythmic patients are resynchronized by the CRT devices. CRT devices are the implantable devices with a microcomputer along with an enclosed battery by a tiny titanium metal case. Insulated wires known as leads are implanted along with the device so as to pass the information signals from the heart to heart device to carry electrical impulses to heart. 
Increase in prevalence rate of the heart diseases globally driving the CRT devices market. Rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style driving the CRT devices market. Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. However, risks in CRT therapy such as surgical site infection, failure in delivering the optimum therapy when it is needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity towards the device material are hindering the growth of CRT devices market. 

Global CRT Devices device market is segmented based on type of device, and end-user 

Based on type of device, CRT market is segmented into 
CRT-pacemakers 
CRT-defibrillators 

 

Get sample Report @  https://www.wiseguyreports.com/sample-request/2868236-global-cardiac-resynchronization-therapy-crt-devices-market-market-estimation-dynamics

 

Based on end-user, CRT devices market is segmented into 
Hospitals 
Clinics 
Ambulatory Surgical Centres 

CRT devices market is expected to show significant growth rate during forecast period due to the high prevalence of cardiac diseases. As per the World Health Organisation (WHO), one of the leading cause of death worldwide is cardiovascular disease, and around 17.5 Mn people died from the cardiovascular diseases which accounted 31% of all the global deaths in the year 2012. Cardiovascular diseases can be prevented by addressing the behavioural risks like cigarette smoking, an unhealthy diet and obesity, players in the market are focusing on the R&D investments to improve the product quality and to minimize manufacturing costs and also focus on development of the devices that are safe to improve compliance of the patient. For example, Medtronic and St. Jude Medical (Abbott laboratories) offer leadless pacemakers for the implantation of the equipment in the right ventricle. Moreover, increase in the usage of MRIs in clinical applications. 

Geographically CRT Devices market is divided into five key regions they are North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be major contributor for CRT devices market owing to factors such as prevalence rates of heart diseases, well established healthcare infrastructure and increase in adaptability rates of CRT devices. Asia-Pacific and Latin American region are expected to witness lucrative growth owing to rapid expansion of industry players within these regions in terms of manufacturing as well as distribution. In addition, increased adaptability rates of a CRT devices and increase in awareness regarding CRT devices are expected to boost the market growth in this region. 

Some of the players in the cardiac resynchronization therapy are Medtronic (U.S.), Abbott Laboratories (U.S.), Biotronik (Germany), LivaNova Plc. (UK), and Boston Scientific Corporation (U.S.) to name a few. 

In February 2017, RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems was launched by Boston Scientific and also received CE Mark which is available for treatment of heart failure in patients across the globe 

In January 2017, Abbott laboratories acquired St. Jude Medical, Inc., for the future growth and to develop a diverse and strong portfolio of medical devices, nutritionals, diagnostics and established branded generic pharmaceuticals.

 

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/2868236-global-cardiac-resynchronization-therapy-crt-devices-market-market-estimation-dynamics

 

Table of Contents -Major Key Points

Executive Summary 
Global Cardiac Resynchronization Therapy (CRT Devices) Market Introduction 
2.1. Global Cardiac Resynchronization Therapy (CRT Devices) Market – Taxonomy 
    2.2. Global Cardiac Resynchronization Therapy (CRT Devices) Market –Definitions 
      2.2.1. Device Type 
      2.2.2. End User 
Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics 
3.1. Drivers 
    3.2. Restraints 
    3.3. Opportunities/Unmet Needs of the Market 
    3.4. Trends 
    3.5. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamic Factors - Impact Analysis 
4. Global Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
    4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 
    4.3. Market Opportunity Analysis 
Global Cardiac Resynchronization Therapy (CRT Devices) Market, By Device Type, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
    5.1. CRT-pacemakers 
      5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.1.3. Market Opportunity Analysis 
    5.2. CRT-defibrillators 
      5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.2.3. Market Opportunity Analysis 
Global Cardiac Resynchronization Therapy (CRT Devices) Market, By End User, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
6.1. Hospitals 
      6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      6.1.3. Market Opportunity Analysis 
    6.2. Clinics 
      6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      6.2.3. Market Opportunity Analysis 
    6.3. Ambulatory Surgical Centers 
      6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      6.3.3. Market Opportunity Analysis 
7. Global Cardiac Resynchronization Therapy (CRT Devices) Market Forecast, By Region, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
1. North America 
      7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      7.1.3. Market Opportunity Analysis 
    7.2. Europe 
      7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      7.2.3. Market Opportunity Analysis 
    7.3. Asia-Pacific 
      7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      7.3.3. Market Opportunity Analysis 
    7.4. Latin America 
      7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      7.4.3. Market Opportunity Analysis 
    7.5. Middle East and Africa 
      7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      7.5.3. Market Opportunity Analysis 
    7.6. Global Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2017 – 2023 
………..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)             

This release was published on openPR.